As you replied to me. Would you also consider replying to my question to you yesterday?
What would it take to shake your confidence in MSB? Is there any scenario where you would consider your investment a mistake?
OTAT response negative?
CHF / CLBP require 3+ years of further p3 trials?
No products on market ( except Japan) in 2 years
No partnerships in next 12 months?
Diluting CR / SP falls below 50c?
After 3+ years of further p3 trials of CHF/CLBP primary endpoints still not met?
Would any of these possible events above change your Buy/Hold sentiment?
I am not a sophisticated investor, so I guess that makes me a 'mum & dad'. I just want to get a sense of where you would draw the line?
Ann: Update on Novartis Agreement, page-729
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.025(2.38%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.06 | $1.06 | $1.02 | $5.734M | 5.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 203347 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 125348 | 6 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.03 |
Change
-0.025 ( 2.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.06 | $1.06 | $1.02 | 953870 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| MSB (ASX) Chart |